At the news
? BULLISHIMPACT 6/10 COURT-RULING filed Jun 16, 2026 at 20:00 ET
On June 17, 2026, the Federal Circuit affirmed the District of New Jersey's denial of Boston Scientific's motion for a preliminary injunction against Stryker regarding the OptaBlate BVN product. The appellate court found no abuse of discretion in the lower court's conclusion that Boston Scientific failed to show a likelihood of success on the merits of its induced infringement claims against Stryker, at least at this preliminary stage. The ruling removes an immediate threat of an injunction blocking Stryker's product launch, which is a clear positive for Stryker but does not resolve the underlying patent litigation, which continues in district court with a scheduled claim construction hearing.
- Stryker won affirmance of the denial of a preliminary injunction; the Federal Circuit found no abuse of discretion by the district court.
- Boston Scientific's request to enjoin Stryker's OptaBlate BVN product from market launch was denied at both the district and appellate levels.
- The ruling was based on substantial questions regarding whether Stryker induces infringement under the district court's tentative claim construction of the term 'reaches' in the '166 patent.
- The underlying patent case (2:25-cv-12700) is still active; a formal claim construction hearing is scheduled before Judge Evelyn Padin in the District of New Jersey.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access